Preprint Brief Report Version 1 Preserved in Portico This version is not peer-reviewed

The Life Cycle of Stemness Explained by Evolutionary Cancer Cell Biology (ECCB)

Version 1 : Received: 18 March 2024 / Approved: 19 March 2024 / Online: 20 March 2024 (12:28:51 CET)
Version 2 : Received: 17 April 2024 / Approved: 17 April 2024 / Online: 18 April 2024 (08:06:19 CEST)
Version 3 : Received: 15 June 2024 / Approved: 17 June 2024 / Online: 17 June 2024 (07:57:12 CEST)

How to cite: Niculescu, V. The Life Cycle of Stemness Explained by Evolutionary Cancer Cell Biology (ECCB). Preprints 2024, 2024031158. https://doi.org/10.20944/preprints202403.1158.v1 Niculescu, V. The Life Cycle of Stemness Explained by Evolutionary Cancer Cell Biology (ECCB). Preprints 2024, 2024031158. https://doi.org/10.20944/preprints202403.1158.v1

Abstract

The evolutionary cancer cell biology ECCB explains the deep homology existent between the life cycle of cancer and protists. Due to their origin and sensitivity to oxygen, all non-gametogenic germ lines and germ stem cells (GSCs), including human adult stem cells (ASCs) and cancer stem cells (CSCs), suffer severe DNADSB damage when exposed to stress oxygen content above 6.0% O2 (Urgermline hyperoxia) as occurring in tissue and bloodstream. As a result, GSCs/ASCs/ CSCs lose their stemness potential and convert from a functional asymmetric cyclic phenotype (ACD phenotype) to a dysfunctional symmetric phenotype capable of defective symmetric proliferation (DSCD) that is, however, unable to repair genomic degradation. Genome reconstruction occurs through evolutionary mechanisms evolved by the common ancestor of amoebozoans, metazoans, and fungi. They complete the cycle by removing the damage, reconstructing the functional genome, and reinstating the ASC phenotype. The stemness life cycle acts not only during carcinogenesis, tumorigenesis, and recurrence but also in the life cycle of protists.

Keywords

stem cell function; dysfunctionality; stress; DNA DSB; repair; genomic integrity

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.